Table 3.
High-Dose Opioid Group (n=478) |
Traditional- Dose Opioid Group (n=500) |
No opioid Group (n=500) |
Test (df) | p-value | |
---|---|---|---|---|---|
Fibromyalgia | 79 (16.5%) | 55 (11.0%) | 31 (6.2%) | χ2 (2) = 26.3 | < 0.001 |
Inflammatory | 35 (7.3%) | 22 (4.4%) | 14 (2.8%) | χ2 (2) = 11.2 | 0.004 |
Bowel Disease | |||||
Low Back Pain | 399 (83.5%) | 371 (74.2%) | 234 (46.8%) | χ2 (2) = 164.5 | < 0.001 |
Migraine Headache | 102 (21.3%) | 112 (22.4%) | 72 (14.4%) | χ2 (2) = 12.0 | 0.002 |
Neck or Joint Pain | 392 (82.0%) | 401 (80.2%) | 315 (63.0%) | χ2 (2) = 58.1 | < 0.001 |
Neuropathy | 86 (18.0%) | 54 (10.8%) | 56 (11.2%) | χ2 (2) = 13.8 | 0.001 |
Rheumatism/ Arthritis |
343 (71.8%) | 321 (64.2%) | 236 (47.2%) | χ2 (2) = 65.4 | < 0.001 |